U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07110337) titled 'Diagnosing Epilepsy To EffeCT Change' on July 24.
Brief Summary: The purpose of this research is to address the challenges of diagnosing and long-term management of epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. This research will compare the Minder System to standard of care in providing reliable seizure data. The Minder System was granted De Novo classification by the U.S. Food and Drug Administration (FDA) and is not investigational.
Participants will consent to join the study and be implant...